Búsqueda avanzada
 array:24 [
  "pii" => "S0213911103717646"
  "issn" => "02139111"
  "doi" => "10.1016/S0213-9111(03)71764-6"
  "estado" => "S300"
  "fechaPublicacion" => "2003-07-01"
  "aid" => "71764"
  "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
  "copyrightAnyo" => "2003"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Gac Sanit. 2003;17:345-6"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1865
    "formatos" => array:3 [
      "EPUB" => 87
      "HTML" => 1355
      "PDF" => 423
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S0213911103717658"
    "issn" => "02139111"
    "doi" => "10.1016/S0213-9111(03)71765-8"
    "estado" => "S300"
    "fechaPublicacion" => "2003-07-01"
    "aid" => "71765"
    "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Gac Sanit. 2003;17:346"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1707
      "formatos" => array:3 [
        "EPUB" => 104
        "HTML" => 1212
        "PDF" => 391
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Nota de los editores"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "346"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Editor's note"
        ]
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Antoni Plasència, Fernando Antoñanzas, Santiago Pérez-Hoyos"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Antoni"
              "apellidos" => "Plasència"
            ]
            1 => array:2 [
              "nombre" => "Fernando"
              "apellidos" => "Antoñanzas"
            ]
            2 => array:2 [
              "nombre" => "Santiago"
              "apellidos" => "Pérez-Hoyos"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717658?idApp=WGSE"
    "url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717658/v1_201310251607/es/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S0213911103717634"
    "issn" => "02139111"
    "doi" => "10.1016/S0213-9111(03)71763-4"
    "estado" => "S300"
    "fechaPublicacion" => "2003-07-01"
    "aid" => "71763"
    "copyright" => "Sociedad Española de Salud Pública y Administración Sanitaria"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Gac Sanit. 2003;17:342-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2695
      "formatos" => array:3 [
        "EPUB" => 93
        "HTML" => 2237
        "PDF" => 365
      ]
    ]
    "es" => array:8 [
      "idiomaDefecto" => true
      "titulo" => "Posibles problemas de falta de objetividad, transparencia, doble publicación y autoría en el análisis coste-efectividad de celecoxib"
      "tienePdf" => "es"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "342"
          "paginaFinal" => "344"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Possible problems of lack of objectivity, transparency, duplicate publication and authorship in the cost-effectiveness analysis of celecoxib"
        ]
      ]
      "contienePdf" => array:1 [
        "es" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "S. Peiró, R. Meneu, V. Ortún, J. Puig"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "S."
              "apellidos" => "Peiró"
            ]
            1 => array:2 [
              "nombre" => "R."
              "apellidos" => "Meneu"
            ]
            2 => array:2 [
              "nombre" => "V."
              "apellidos" => "Ortún"
            ]
            3 => array:2 [
              "nombre" => "J."
              "apellidos" => "Puig"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "es"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717634?idApp=WGSE"
    "url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717634/v1_201310251607/es/main.assets"
  ]
  "es" => array:9 [
    "idiomaDefecto" => true
    "titulo" => "Réplica"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "345"
        "paginaFinal" => "346"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A. Moreno, E. Vargas, J. Soto, J. Rejas"
        "autores" => array:4 [
          0 => array:3 [
            "nombre" => "A."
            "apellidos" => "Moreno"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "E&#46;"
            "apellidos" => "Vargas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "J&#46;"
            "apellidos" => "Soto"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "J&#46;"
            "apellidos" => "Rejas"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "<span class="elsevierStyleItalic">Servicio de Farmacolog&#237;a Cl&#237;nica&#46; Hospital Cl&#237;nico San Carlos&#46; Madrid</span>"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "<span class="elsevierStyleItalic">Unidad M&#233;dica&#46; Pfizer S&#46;A&#46; Madrid&#46; Espa&#241;a</span>"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Author&#39;s reply"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "bibliografia" => array:2 [
      "titulo" => "Bibliograf&#237;a"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:7 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis&#58; The CLASS study&#58; a randomised controlled trial&#46; Celecoxib Long-term Arthritis Safety Study"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "F&#46;E&#46; Silverstein"
                            1 => "G&#46; Faich"
                            2 => "J&#46;L&#46; Goldstein"
                            3 => "L&#46;S&#46; Simon"
                            4 => "T&#46; Pincus"
                            5 => "A&#46; Whelton"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "JAMA"
                        "fecha" => "2000"
                        "volumen" => "284"
                        "paginaInicial" => "1247"
                        "paginaFinal" => "1255"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10979111"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "on behalf of CLASS investigators&#46; Gastrointestinal &#40;GI&#41; event rates in the CLASS study&#58; 6 months vs longer-term follow-up analyses"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "J&#46;L&#46; Goldstein"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2002"
                        "volumen" => "122"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "A-469"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Observational study of upper gastrointestinal haemorrhage in elderly patients given selective ciclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "M&#46; Mamdani"
                            1 => "P&#46;A&#46; Rochon"
                            2 => "D&#46;N&#46; Juurlink"
                            3 => "A&#46; Kopp"
                            4 => "G&#46;M&#46; Anderson"
                            5 => "G&#46; Naglie"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "BMJ"
                        "fecha" => "2002"
                        "volumen" => "325"
                        "paginaInicial" => "624"
                        "paginaFinal" => "627"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12242172"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "por el Grupo de Estudio Patolog&#237;a TDS&#46; El uso de Coxibs no se asocia a aumento de riesgo de hemorragia digestiva alta&#46; VI Congreso de la Asociaci&#243;n Espa&#241;ola de Gastroenterolog&#237;a"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "L&#46;A&#46; Garc&#237;a Rodr&#237;guez"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Gastroenterol Hepatol"
                        "fecha" => "2003"
                        "volumen" => "26"
                        "paginaInicial" => "183"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gastroprotective therapy and risk of gastrointestinal ulcers&#58; risk reduction by COX-2 therapy"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "F&#46; Wolfe"
                            1 => "J&#46; Anderson"
                            2 => "T&#46;A&#46; Burke"
                            3 => "L&#46;M&#46; Arguelles"
                            4 => "D&#46; Pettitt"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Rheumatol"
                        "fecha" => "2002"
                        "volumen" => "29"
                        "paginaInicial" => "467"
                        "paginaFinal" => "473"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11908558"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Inhibidores selectivos de la ciclooxigenasa-2 &#40;Coxibs&#41; y morbilidad cardiovascular"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "L&#46;M&#46; Ruilope"
                            1 => "A&#46; Coca"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Med Clin &#40;Barc&#41;"
                        "fecha" => "2002"
                        "volumen" => "118"
                        "paginaInicial" => "219"
                        "paginaFinal" => "221"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "W&#46;A&#46; Ray"
                            1 => "T&#46;M&#46; MacDonald"
                            2 => "D&#46;H&#46; Solomon"
                            3 => "D&#46;J&#46; Graham"
                            4 => "J&#46; Avorn"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Pharmacoepi Drug Saf"
                        "fecha" => "2003"
                        "volumen" => "12"
                        "paginaInicial" => "67"
                        "paginaFinal" => "70"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "es"
  "url" => "/02139111/0000001700000004/v1_201310251607/S0213911103717646/v1_201310251607/es/main.assets"
  "Apartado" => array:4 [
    "identificador" => "677"
    "tipo" => "SECCION"
    "es" => array:2 [
      "titulo" => "Cartas al Director"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "es"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/02139111/0000001700000004/v1_201310251607/S0213911103717646/v1_201310251607/es/main.pdf?idApp=WGSE&text.app=https://gacetasanitaria.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0213911103717646?idApp=WGSE"
]
Compartir
Métricas
Comité editorial
Publique en esta revista
julio - agosto 2003 Réplica
Información de la revista
Artículo anterior | Artículo siguiente
Vol. 17. Núm. 4.
Páginas 345-346 (julio - agosto 2003)
Respuestas rápidas
Compartir
Compartir
Imprimir
Descargar PDF
Más opciones de artículo
ePub
Estadísticas
Vol. 17. Núm. 4.
Páginas 345-346 (julio - agosto 2003)
DOI: 10.1016/S0213-9111(03)71764-6
Open Access
Réplica
Author's reply
Visitas
4421
Descargar PDF
A. Morenoa, E. Vargasa, J. Sotob, J. Rejasb
a Servicio de Farmacología Clínica. Hospital Clínico San Carlos. Madrid
b Unidad Médica. Pfizer S.A. Madrid. España
Este artículo ha recibido
4421 Visitas

Under a Creative Commons license
Información del artículo
Bibliografía
Descargar PDF
Estadísticas
El Texto completo está disponible en PDF
Bibliografía
[1.]
F.E. Silverstein, G. Faich, J.L. Goldstein, L.S. Simon, T. Pincus, A. Whelton, et al.
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study.
JAMA, 284 (2000), pp. 1247-1255
Medline
[2.]
J.L. Goldstein.
on behalf of CLASS investigators. Gastrointestinal (GI) event rates in the CLASS study: 6 months vs longer-term follow-up analyses.
Gastroenterology, 122 (2002), pp. A-469
[3.]
M. Mamdani, P.A. Rochon, D.N. Juurlink, A. Kopp, G.M. Anderson, G. Naglie, et al.
Observational study of upper gastrointestinal haemorrhage in elderly patients given selective ciclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs.
BMJ, 325 (2002), pp. 624-627
Medline
[4.]
L.A. García Rodríguez.
por el Grupo de Estudio Patología TDS. El uso de Coxibs no se asocia a aumento de riesgo de hemorragia digestiva alta. VI Congreso de la Asociación Española de Gastroenterología.
Gastroenterol Hepatol, 26 (2003), pp. 183
[5.]
F. Wolfe, J. Anderson, T.A. Burke, L.M. Arguelles, D. Pettitt.
Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
J Rheumatol, 29 (2002), pp. 467-473
Medline
[6.]
L.M. Ruilope, A. Coca.
Inhibidores selectivos de la ciclooxigenasa-2 (Coxibs) y morbilidad cardiovascular.
Med Clin (Barc), 118 (2002), pp. 219-221
[7.]
W.A. Ray, T.M. MacDonald, D.H. Solomon, D.J. Graham, J. Avorn.
COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Pharmacoepi Drug Saf, 12 (2003), pp. 67-70
Copyright © 2003. Sociedad Española de Salud Pública y Administración Sanitaria

Suscríbase a la newsletter

Tabla de contenidos
Publique en
Gaceta Sanitaria
Podcast
El copago farmacéutico en España tras la reforma del año 2012 desde la perspectiva del usuario. ¿Evidencias de inequidad?
Vídeo selección del editor
María Victoria Zunzunegui conversando sobre mortalidad en la pandemia con Joan Carles March
Ver vídeo
María Victoria Zunzunegui conversando sobre mortalidad en la pandemia con Joan Carles March
Gaceta Sanitaria se adhiere a los principios y procedimientos dictados por el Committee on Publication Ethics (COPE)
www.publicationethics.org.

Gaceta Sanitaria sigue las recomendaciones para la preparación, presentación y publicación de trabajos académicos en revistas biomédicas

Descargar PDF
Idiomas
Gaceta Sanitaria
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?